PA
Perceptive Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,249,669
| Closed | -$2.27M | – | 107 |
|
2024
Q4 | $2.27M | Sell |
3,249,669
-3,849,513
| -54% | -$2.69M | 0.06% | 83 |
|
2024
Q3 | $10.3M | Hold |
7,099,182
| – | – | 0.22% | 69 |
|
2024
Q2 | $51.8M | Hold |
7,099,182
| – | – | 1.25% | 22 |
|
2024
Q1 | $42M | Hold |
7,099,182
| – | – | 0.74% | 46 |
|
2023
Q4 | $52M | Buy |
7,099,182
+2,060,199
| +41% | +$15.1M | 1.16% | 26 |
|
2023
Q3 | $19.6M | Hold |
5,038,983
| – | – | 0.65% | 43 |
|
2023
Q2 | $29.1M | Hold |
5,038,983
| – | – | 0.84% | 39 |
|
2023
Q1 | $32.8M | Hold |
5,038,983
| – | – | 0.97% | 33 |
|
2022
Q4 | $13.9M | Hold |
5,038,983
| – | – | 0.39% | 50 |
|
2022
Q3 | $14.7M | Hold |
5,038,983
| – | – | 0.43% | 53 |
|
2022
Q2 | $9.68M | Buy |
5,038,983
+1,428,571
| +40% | +$2.74M | 0.3% | 61 |
|
2022
Q1 | $29.3M | Hold |
3,610,412
| – | – | 0.59% | 43 |
|
2021
Q4 | $33.1M | Hold |
3,610,412
| – | – | 0.51% | 50 |
|
2021
Q3 | $45.1M | Hold |
3,610,412
| – | – | 0.66% | 38 |
|
2021
Q2 | $40.8M | Hold |
3,610,412
| – | – | 0.53% | 48 |
|
2021
Q1 | $54.7M | Buy |
3,610,412
+200,000
| +6% | +$3.03M | 0.69% | 40 |
|
2020
Q4 | $39.3M | Hold |
3,410,412
| – | – | 0.42% | 54 |
|
2020
Q3 | $26.4M | Hold |
3,410,412
| – | – | 0.39% | 59 |
|
2020
Q2 | $37.5M | Hold |
3,410,412
| – | – | 0.61% | 39 |
|
2020
Q1 | $37.3M | Hold |
3,410,412
| – | – | 0.97% | 24 |
|
2019
Q4 | $52M | Hold |
3,410,412
| – | – | 1.03% | 21 |
|
2019
Q3 | $50.3M | Hold |
3,410,412
| – | – | 1.36% | 20 |
|
2019
Q2 | $39.6M | Hold |
3,410,412
| – | – | 0.91% | 28 |
|
2019
Q1 | $38.5M | Hold |
3,410,412
| – | – | 1.09% | 26 |
|
2018
Q4 | $27.8M | Hold |
3,410,412
| – | – | 1.06% | 26 |
|
2018
Q3 | $55.4M | Hold |
3,410,412
| – | – | 1.48% | 23 |
|
2018
Q2 | $67.3M | Buy |
+3,410,412
| New | +$67.3M | 1.76% | 13 |
|